knowledge -WSS

knowledge

author：comprehensive 2025-08-23 23:16:58 - browse：337

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Community addresses injustice for Long Island mothers

WSS

Americans' trust in science, scientist continues decline: Report

Australia's humpback populations rebound raising hopes of marine scientists

Community addresses injustice for Long Island mothers

Pfizer plans to depart BIO

What causes an itch? Researchers may have solved the mystery

What PEPFAR has meant on the ground in Ukraine

hotspot

knowledge

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Meta looks to target Twitter with a rival app called Threads

Heart attack and stroke risk calculators need revising

Teach medical students about patients with intellectual disabilities

Medicare details structure of new drug price negotiation program

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

ChatGPT in medicine: STAT answers readers' burning questions

Pfizer plans to depart BIO

Bright Health sells Medicare Advantage business to Molina

Roche to buy Carmot Therapeutics, developer of obesity drugs

hotspot

4th of July breaks record for highest global temperature ever measured

New case study details death in closely watched Alzhiemer's trial

7 people shot in DC, police say

Connecting traumatic brain injury and domestic violence

When is a doctor not a doctor? Try when patients address women doctors

The woman behind the Dana Farber

Wikipedia

explore

focus

explore